？ HUANG Y X, REN J, REN T B, et al. Bone marrow stromal cells cultured on poly (lactide-co-glycolide)/nano-hydroxyapatite composites with chemical immobilization of Arg-Gly-Asp peptide and preliminary bone regeneration of mandibular defect thereof [J]. J Biomed Mater Res Part A, 2010, 95A(4): 993–1003.
[2]
？ HO M L, FU Y C, WANG G J, et al. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite [J]. J Controlled Release, 2008, 128(2): 142–148.
[3]
？ SHI X T, WANG Y J, REN L, et al. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications [J]. Pharmaceut Res, 2009, 26(2): 422–430.
[4]
？ WANG X D, WANG Y J, WEI K, et al. Drug Distributton Within Poly (ε-Caprolactone)/hydroxyapatite Nanoparticle Composite Microspheres And in vitro Release [J]. J Chin Ceram Soc, 2008, 36(9): 1225–1230.
[5]
？ NIE H M, WANG C H. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA [J]. J Controlled Release, 2007, 120(1–2): 111–121.
[6]
References:
[7]
？ KIM T K, YOON J J, LEE D S, et al. Gas foamed open porous biodegradable polymeric microspheres [J]. Biomaterials, 2006, 27(2): 152–159.
[8]
？ YANG Y Y, CHIA H H, CHUNG T S. Effect of preparation temperature on the characteristics and release pro?les of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/ evaporation method [J]. J Controlled Release, 2000, 69(1): 81–96.
[9]
？ ZHANG H, GAO S. Temozolomide/PLGA microparticles and antitumor activity against Glioma C6 cancer cells in vitro [J]. Int J Pharm, 2007, 329(1/2): 122–128.
[10]
？ TANG J, CHEN J Y, LIU J, et al. Calcium phosphate embedded PLGA nanoparticles: A promising gene delivery vector with high gene loading and transfection efficiency [J]. Int J Pharm, 2012, 431(1/2): 210–221.
[11]
？ WEIKEL A L, OWENS S G, MOROZOWICH N L, et al. Miscibility of choline-substituted polyphosphazenes with PLGA and osteoblast activity on resulting blends [J]. Biomaterials, 2010, 31(33): 8507–8515.
[12]
？ SCHNEIDER O D, LOHER S, BRUNNER T J, et al. Flexible, silver containing nanocomposites for the repair of bone defects: antimicrobial effect against E. coli infection and comparison to tetracycline containing scaffolds [J]. J Mater Chem, 2008, 18(23): 2679–2684.
[13]
？ ZHONG Z, WEI Y, ZARA J N, et al. The use of BMP-2 coupled Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects [J]. Biomaterials, 2010, 31(35): 9293–9300.
[14]
？ PAN H, JIANG H L, CHEN W L. The biodegradability of electrospun Dextran/PLGA scaffold in a ?broblast/macrophage co-culture [J]. Biomaterials, 2008, 29(2): 1583–1592.
[15]
？ XU Q G, CZEMUSZKA J T. Controlled release of amoxicillin from hydroxyapatite -coated poly(lactic-co-glycolic acid) microspheres [J]. J Controlled Release, 2008, 127(2): 146–153.
[16]
？ ARA M, WATANABE M, IMAI Y. Effect of blending calcium compounds on hydrolytic degradation of poly(dl-lactic acid-co-glycolic acid)[J]. Biomaterials, 2002, 23(12): 2479–2483.
[17]
？ KIM M S, AHN H H, SHIN Y N, et al. An in vivo study of the host tissue response to subcutaneous implantation of PLGA-and/or porcine small intestinal submucosa-based scaffolds [J]. Biomaterials, 2007, 28(34): 5137–5143.
[18]
？ BHARDWAJ U, SURA R, PAPADIMITRAKOPOULOS F, et al. PLGA/PVA hydrogel composites for long-term in?ammation control following s.c. implantation [J]. Int J Pharm, 2010, 384(1–2): 78–86.
[19]
？ NIE H M, HO M L, WANG C K, et al. BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone [J]. Biomaterials, 2009, 30(5): 892–901.
[20]
？ LIU T Y, CHEN S Y, LIU D M, et al. On the study of BSA-loaded calcium-deficient hydroxyapatite nano-carriers for controlled drug delivery [J]. J Controlled Release, 2005, 107(1): 112–121.
[21]
？ XUE J M, SHI M. PLGA/mesoporous silica hybrid structure for controlled drug release [J]. J Controlled Release, 2004, 98(2): 209–217.
[22]
？ HENCH L L, WILSON J. Advanced series in ceramics [M]. Singapore: World Scientific, 1993: 150
[23]
？ DOROZHKIN S V. Surface reactions of apatite dissolution [J]. J Colloid Interface Sci, 1997, 191: 489–497.
[24]
？ SHEN H, HU X X, YANG F, et al. An injectable scaffold: rhBMP-2-loaded poly(lactide-co-glycolide)/hydroxyapatite composite microspheres [J]. Acta Biomater, 2010, 6(2): 455–465.
[25]
？ OKADA M, FURUKAWA K, SERIZAWA T, et al. Interfacial interactions between calcined hydroxyapatite nanocrystals and substrates [J]. Langmuir, 2009, 25(11): 6300–6306.
[26]
？ RENI M, MASON W, ZAJA F, et al. Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial [J]. Eur J Cancer, 2004, 40(11): 1682–1688.
[27]
？ ZHANG Y H, ZHANG H, LIU J M, et al. Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats [J]. Med Oncol, 2011, 28(3): 901–906.
[28]
？ BREM S, TYLER B, LI K, et al. Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model [J]. Cancer Chemoth Pharm, 2007, 60(5): 643–650.
[29]
？ ZHANG D Y, TIAN A, XUE X X, et al. The effect of temozolomide/ PLGA/nano-hydroxyapatite microspheres on glioma U87 cells behavior [J]. Int J Mol Sci, 2012, 13(1): 1109–1125.
[30]
？ HANCOCK B C, ZOGRAFI G. The relationship between the glass transition temperature and the water content of amorphous pharmaceutical solids [J]. Pharm Res, 1994, 11(4): 471–477.
